Skip to search formSkip to main contentSkip to account menu

cisatracurium besylate

Known as: (1R,1'R,2R,2'r)-atracurium besylate, (1R,2R)-2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium Benzenesulfonate, Pentamethylene Ester, (1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate 
A non-depolarizing skeletal muscle relaxant of the benzylisoquinolinium class. Cisatracurium besylate acts as a competitive acetylcholine antagonist… 
National Institutes of Health

Related topics

Related topics

7 relations
5 ML Cisatracurium 2 MG/ML Injection [Nimbex]CisatracuriumCisatracurium-KationDrug Allergy

Narrower (2)

51W89Nimbex

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Comparison of Different Muscle-Relaxant Anesthetics on Growth, Migration and Invasion of Gastric Cancer Cells.
BACKGROUND/AIM Muscle relaxants, also known as neuromuscular blocking agents, can block nerve impulses to the muscles and are… 
2014
2014
The effect of different storage temperature on the pharmacodynamic dose-response of cisatracurium besylate: 9AP5-1
2011
2011
Presynaptic facilitatory adenosine A2A receptors mediate fade induced by neuromuscular relaxants that exhibit anticholinesterase activity
1. Pancuronium, cisatracurium and vecuronium are antinicotinic agents that, in contrast with d‐tubocurarine and hexamethonium… 
2002
2002
Cisatracurium infusion for neuromuscular blockade in the pediatric intensive care unit: A dose-finding study
Objective To evaluate the safety and efficacy of cisatracurium besylate, a neuromuscular blocking agent in infants zero to 2 yrs… 
2001
2001
Dose–Response Relationship and Infusion Requirement of Cisatracurium Besylate in Infants and Children during Nitrous Oxide–Narcotic Anesthesia
Background To determine the effect of age on the dose–response relation and infusion requirement of cisatracurium besylate in… 
2001
2001
Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane, or propofol
PurposeThe present study investigated the interaction between the cumulative dose requirements of cisatracurium and anesthesia… 
1998
1998
Stability of cisatracurium besylate in vials, syringes, and infusion admixtures.
The stability of cisatracurium besylate was studied. Cisatracurium (as besylate) 2 mg/mL in 5- and 10-mL unopened vials and 10 mg… 
1998
1998
HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products.
1996
1996
Preclinical pharmacology of cisatracurium besylate
Atracurium is a mixture of 10 isomers. Six of the 10 isomers have been prepared and evaluated for neuromuscular, autonomic and… 
1993
1993
Neuromuscular blockade in the ICU.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)